TEL-AVIV, Israel and RALEIGH, N.C. - RedHill Biopharma Ltd. (NASDAQ: NASDAQ:RDHL), a specialty biopharmaceutical company with a market capitalization of $7.53 million, today announced the initiation ...
A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback